Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
KÄÄPÄ BioTech Oy
OY
Active
Y-tunnus 2917439-7
Teilinummentie 2, 09120
Karjalohja
Support services to forestry
·
NACE 0240
Est. 2018 · 8 years old
26 employees
kaapabiotech.com
Share
Finland
/
Companies
/
Support services to forestry
/
KÄÄPÄ BioTech Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
4M
3M
2M
1M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 2M (+100% vs 2023)
2M
+100%
2024
2025: 3M (+50% vs 2024)
3M
+50%
2025
EBITDA
EUR millions
0M
0M
-1M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: -1M
-1M
2023
2024: 0M (+100% vs 2023)
0M
2024
2025: -1M
-1M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
2 642
1 927
1 018
930
847
Staff expenses
−1 295
−1 157
−943
−832
−644
EBITDA
−849
−404
−646
−251
−109
Depreciation & amort.
−699
−467
−236
−159
−27
EBIT
−1 547
−871
−882
−409
−136
Net financials
−71
−43
−44
−27
−18
Profit before tax
−1 618
−914
−926
−437
−154
Tax
−0
−0
−0
−0
−2
Net profit
−1 618
−914
−926
−437
−152
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
8 926
3 465
2 546
1 379
1 179
Equity
6 723
619
1 016
441
108
Long-term debt
995
1 651
1 090
649
351
Short-term debt
1 208
1 195
441
289
720
Total debt
2 203
2 846
1 531
939
1 071
Financial ratios
5-year trend
EBITDA margin
−32,1 %
This company
15,8 %
Market median
This company
Market median
303% below market
2021
2025
Equity ratio
75,3 %
This company
38,2 %
Market median
This company
Market median
97% above market
2021
2025
Return on equity
−24,1 %
This company
18,4 %
Market median
This company
Market median
231% below market
2021
2025
Net profit margin
−61,3 %
This company
8,1 %
Market median
This company
Market median
857% below market
2021
2025
Asset turnover
0,30×
This company
1,12×
Market median
This company
Market median
73% below market
2021
2025
Debt / equity
0,33×
This company
0,62×
Market median
This company
Market median
47% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on KÄÄPÄ BioTech Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
